Synact Pharma med nya angreppssätt
Premium News
2019-10-08
11:53
Redeye tog nyligen upp analysbevakning av Synact Pharma. Aktien handlas mellan Redeye Bear Case och Redeye Base Case. Vi har tagit en pratstund med ansvarig analytiker Ludvig Svensson.
DM
David Madeling
Get Premium, Get Satisfied
Get this article and many more exclusive features with a premium membership. Full access to all articles.
Already a member?
Sign in
Disclosures and disclaimers